Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Goodwill & Intangibles of $1.3 billion for Q1 2026, down 1.18% year-over-year from $1.3 billion in Q1 2025, and down 1.18% quarter-over-quarter from $1.3 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 1.18% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 1.18% YoY), while the FY2026 annual figure was $1.3 billion, down 1.18% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $1.3 billion, down from $1.3 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $1.3 billion in Q1 2025, with the low at $417.0 million in Q1 2022.
- The 5-year median for Goodwill & Intangibles is $494.0 million (2024), against an average of $689.3 million.
- The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles declined 24.04% in 2022, then jumped 157.49% in 2025.
- Dr Reddys Laboratories' Goodwill & Intangibles stood at $441.0 million in 2022, then grew by 17.01% to $516.0 million in 2023, then slipped by 4.26% to $494.0 million in 2024, then surged by 157.49% to $1.3 billion in 2025, then declined by 1.18% to $1.3 billion in 2026.
- Business Quant data shows RDY's Goodwill & Intangibles at $1.3 billion in Q1 2026, $1.3 billion in Q1 2025, and $494.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Mar 31, 2024 | 494.00 Mn |
| Jun 30, 2023 | 516.00 Mn |
| Mar 31, 2023 | 428.00 Mn |
| Jun 30, 2022 | 441.00 Mn |
| Mar 31, 2022 | 417.00 Mn |
| Mar 31, 2021 | 549.00 Mn |
| Dec 31, 2020 | 562.00 Mn |
| Sep 30, 2020 | 624.00 Mn |
| Mar 31, 2020 | 420.00 Mn |
| Dec 31, 2019 | 423.00 Mn |
| Sep 30, 2019 | 621.00 Mn |
| Mar 31, 2019 | 698.00 Mn |
| Dec 31, 2018 | 690.00 Mn |
| Jun 30, 2018 | 720.00 Mn |
| Mar 31, 2018 | 710.00 Mn |
| Dec 31, 2017 | 755.00 |
| Sep 30, 2017 | 778.00 |
| Jun 17, 2017 | 752.00 Mn |